OFPP Seeks to Debunk Myths about Debriefings
Client Alert | less than 1 min read | 01.27.17
On January 5, 2017, the Office of Federal Procurement Policy (OFPP) issued its third "Myth-busting" memorandum, specifically addressing misconceptions about debriefings. By issuing this memorandum, OFPP seeks to encourage the use of debriefings as a tool that could contribute to a potentially more competitive supplier base and also allow agencies to evaluate and improve their own processes. In addition to attempting to debunk some common myths about debriefings, the memorandum sets forth best practices, including the adoption or establishment of a debriefing guide.
Contacts
Insights
Client Alert | 4 min read | 04.08.26
Cosmetics Under the Microscope: FDA’s Expanding Regulatory Reach Under MoCRA
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marked the most significant expansion of FDA’s authority over cosmetics in 80 years — and the agency is putting that authority to work. From the launch of a new adverse event reporting tool to forthcoming rules on fragrance allergens and good manufacturing practices (GMP), FDA is reshaping the regulatory landscape for manufacturers, packers, and distributors of cosmetic and personal care products.
Client Alert | 11 min read | 04.08.26
Client Alert | 3 min read | 04.07.26
Answering the Top Seven Questions About Pending Section 301 Deadlines
Client Alert | 3 min read | 04.07.26
EU Pharma Package: Fiscal Imports in the Supply Chain Compromise Proposal
